Literature DB >> 24729105

Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

Jack E James1.   

Abstract

Mesh：

Year:  2014        PMID： 24729105     DOI： 10.1007/s10654-014-9898-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  46 in total

Review 1.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine.

Authors:  Andrea D Weston; Leroy Hood
Journal:  J Proteome Res       Date:  2004 Mar-Apr       Impact factor: 4.466

2.  Has the genomic revolution failed?

Authors:  Joseph S Alpert; Qin M Chen
Journal:  Clin Cardiol       Date:  2012-01-25       Impact factor: 2.882

Review 3.  Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease.

Authors:  John P A Ioannidis; Ioanna Tzoulaki
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

4.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

Review 5.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

6.  Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.

Authors:  Stacie D Adams; James P Evans; Arthur S Aylsworth
Journal:  N C Med J       Date:  2013 Nov-Dec

Review 7.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

8.  Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice.

Authors:  George Davey Smith
Journal:  Int J Epidemiol       Date:  2011-06       Impact factor: 7.196

Review 9.  Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity.

Authors:  Karen E Hoffman
Journal:  Semin Radiat Oncol       Date:  2012-10       Impact factor: 5.934

10.  Why calls for more routine carotid stenting are currently inappropriate: an international, multispecialty, expert review and position statement.

Authors:  Anne L Abbott; Mark A Adelman; Andrei V Alexandrov; P Alan Barber; Henry J M Barnett; Jonathan Beard; Peter Bell; Martin Björck; David Blacker; Leo H Bonati; Martin M Brown; Clifford J Buckley; Richard P Cambria; John E Castaldo; Anthony J Comerota; E Sander Connolly; Ronald L Dalman; Alun H Davies; Hans-Henning Eckstein; Rishad Faruqi; Thomas E Feasby; Gustav Fraedrich; Peter Gloviczki; Graeme J Hankey; Robert E Harbaugh; Eitan Heldenberg; Michael G Hennerici; Michael D Hill; Timothy J Kleinig; Dimitri P Mikhailidis; Wesley S Moore; Ross Naylor; Andrew Nicolaides; Kosmas I Paraskevas; David M Pelz; James W Prichard; Grant Purdie; Jean-Baptiste Ricco; Peter A Ringleb; Thomas Riles; Peter M Rothwell; Peter Sandercock; Henrik Sillesen; J David Spence; Francesco Spinelli; Jonathon Sturm; Aaron Tan; Ankur Thapar; Frank J Veith; Tissa Wijeratne; Wei Zhou
Journal:  Stroke       Date:  2013-03-19       Impact factor: 7.914
View more
  10 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Molecular and genomic sciences in health: apply the established rules of evidence.

Authors:  Oliver Razum; Albrecht Jahn
Journal:  Int J Public Health       Date:  2015-10-26       Impact factor: 3.380

Review 3.  Contributions of the UK biobank high impact papers in the era of precision medicine.

Authors:  Peter Glynn; Philip Greenland
Journal:  Eur J Epidemiol       Date:  2020-01-28       Impact factor: 8.082

4.  Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study.

Authors:  Yuqi Wang; Liangxu Wang; Yanli Su; Li Zhong; Bin Peng
Journal:  BMC Endocr Disord       Date:  2021-10-22       Impact factor: 2.763

Review 5.  The commercialization of university-based research: Balancing risks and benefits.

Authors:  Timothy Caulfield; Ubaka Ogbogu
Journal:  BMC Med Ethics       Date:  2015-10-14       Impact factor: 2.652

6.  Risk prediction model of gestational diabetes mellitus based on nomogram in a Chinese population cohort study.

Authors:  Xiaomei Zhang; Xin Zhao; Lili Huo; Ning Yuan; Jianbin Sun; Jing Du; Min Nan; Linong Ji
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

7.  Managing the moral expansion of medicine.

Authors:  Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2022-09-22       Impact factor: 2.834

8.  Mastering variation: variance components and personalised medicine.

Authors:  Stephen Senn
Journal:  Stat Med       Date:  2015-09-28       Impact factor: 2.373

9.  Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis.

Authors:  Ruth P Norris; Rosie Dew; Linda Sharp; Alastair Greystoke; Stephen Rice; Kristina Johnell; Adam Todd
Journal:  BMC Med       Date:  2020-10-23       Impact factor: 8.775

10.  Plastic diagnostics: The remaking of disease and evidence in personalized medicine.

Authors:  Sara Green; Annamaria Carusi; Klaus Hoeyer
Journal:  Soc Sci Med       Date:  2019-05-18       Impact factor: 5.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.